Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
57 participants
OBSERVATIONAL
2024-10-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary outcomes:
1. Assessment of pregnancy related AKI maternal outcome (complete recovery , partial recovery or progress to ESRD) within 3 months duration
2. To identify predictors of unfavorable outcome of patient with pregnancy related AKI
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Kidney Disease in Pregnant Females
NCT06738069
Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients
NCT06857188
Prognosis of Acute Kidney Injury:China Collaborative Study on AKI(CCS-AKI)Study
NCT03061786
PREDICT: Thinking About Pregnancy Risk in Women With Kidney Disease
NCT04370769
Screening of Congenital Anomalies of Kidney
NCT06440499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PR-AKI has a major risk factors include preeclampsia which is the most common cause (15-20%) , hyperemesis gravidarum , acute fatty liver of pregnancy and placental abruption , puerperal sepsis and septic abortion .The maternal outcome of pregnancy related AKI include complete recovery with return of serum creatinine to normal (\> 1.4 mg /dl ) about (40-75% ), partial recovery(4-9% require dialysis about 4 months after delivery) , progress to End stage renal disease (1.5 - 2.5 %) or maternal mortality . The maternal mortality rate (MMR) increases with increasing severity of pregnancy-related complications and can range from 13 to 24% in developing countries due to PR-AKI .
Timely identification of patients and management of underlying conditions is considered the cornerstone to improve maternal outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AKI as defined by KDIGO definition as follows:
1. Increase in serum creatinine \> 0.3 mg/dl within 48
2. Increase in serum creatinine \> 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days.
3. urine volume of \< .5 ml / kg / hours
Exclusion Criteria
* Patients with AKI not related to pregnancy.
* Patients with uncertain history for incident time of AKI.
* Patients refuse to participate in the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Saber Mohamed Ali
MBBCH , principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Saber, MBBCH
Role: PRINCIPAL_INVESTIGATOR
Assiut university _ faculty of medicine
Mahmoud Ali, MBBCH
Role: STUDY_DIRECTOR
Assiut university _ faculty of medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pregnancy related AKI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.